AVEO Oncology
Founded 2001 · 205 employees on LinkedIn · 1 known investors
Find your way into AVEO Oncology
Sign up to see every warm intro you have to AVEO Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AVEO Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AVEO, operating as a subsidiary of LG Chem, develops and commercializes oncology medicines aimed at cancer patients seeking effective treatments that maintain quality of life. The company operates a portfolio of on-market and in-development therapeutic products globally.
Founders & leadership
Investors · 1
In the news
Frequently asked questions
- What does AVEO Oncology do?
- AVEO, operating as a subsidiary of LG Chem, develops and commercializes oncology medicines aimed at cancer patients seeking effective treatments that maintain quality of life. The company operates a portfolio of on-market and in-development therapeutic products globally.
- Who are AVEO Oncology's investors?
- AVEO Oncology's investors include New Enterprise Associates (NEA).

